Red blood cell storage duration and mortality in patients undergoing percutaneous coronary intervention - 05/08/11
, Christian Janssen, PhD a, b, Eric B. Fretz, MD a, Brian Berry, MD a, Alex J. Chase, MBChB, PhD c, Anthony Della Siega, MD a, Ronald G. Carere, MD d, Anthony Fung, MBBS e, Gerald Simkus, MD f, W. Peter Klinke, MD a, J. David Hilton, MD aRésumé |
Background |
Blood transfusion has been associated with an increased mortality in patients undergoing percutaneous coronary intervention (PCI). Although the reasons for this remain unclear, it may be related to the structural and functional changes occurring within red blood cells (RBCs) during storage. We investigated whether RBC storage duration was associated with mortality in patients requiring transfusion after PCI.
Methods |
We collected data on all RBC transfusions occurring within 10 days of PCI (excluding those related to cardiac surgery) using the British Columbia Cardiac Registry and Central Transfusion Registry. Transfusion details were analyzed according to 30-day survival.
Results |
From a total of 32,580 patients undergoing PCI, 909 (2.8%) patients received RBCs with a mean storage duration of 25 ± 10 days. In these 909 patients, mean transfusion volumes were lower in survivors (2.8 ± 2.1 vs 3.8 ± 2.9 U, P = .002) than those who died within 30 days. In a multivariate analysis to adjust for baseline risk, mean RBC storage age (HR 1.02 [95% CI 1.01-1.04], P = .002) and transfusion volume (HR 1.26 [95% CI 1.18-1.34], P < .001) both predicted 30-day mortality. Transfused patients who received only older blood (RBC min age >28 days) appeared to be at greater risk of death (HR 2.49 [95% CI 1.45-4.25], P = .001).
Conclusion |
Red blood cell transfusion is associated with increased 30-day mortality in patients undergoing PCI. Although current transfusion practice permits RBC storage for up to 42 days, the use of older red cells may pose an additional hazard to this patient group.
Le texte complet de cet article est disponible en PDF.Plan
| Grant Support Victoria Foundation (Canadian Charity No. 130650898RR0001). |
Vol 159 - N° 5
P. 876-881 - mai 2010 Retour au numéro
Article précédent
- Incidence, correlates, and clinical impact of nuisance bleeding after antiplatelet therapy for patients with drug-eluting stents
- Itsik Ben-Dor, Rebecca Torguson, Mickey Scheinowitz, Yanlin Li, Cedric Delhaye, Kohei Wakabayashi, Gabriel Maluenda, Asmir I. Syed, Sara D. Collins, Manuel A. Gonzalez, Michael A. Gaglia, Zhenyi Xue, Kimberly Kaneshige, Lowell F. Satler, William O. Suddath, Kenneth M. Kent, Augusto D. Pichard, Ron Waksman
- Endothelin-1 release in acute myocardial infarction as a predictor of long-term prognosis and no-reflow assessed by contrast-enhanced magnetic resonance imaging
- Ingo Eitel, Marek Nowak, Clemens Stehl, Volker Adams, Georg Fuernau, Lysann Hildebrand, Steffen Desch, Gerhard Schuler, Holger Thiele
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?